0002136711-26-000001.txt : 20260528 0002136711-26-000001.hdr.sgml : 20260528 20260528162815 ACCESSION NUMBER: 0002136711-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260528 DATE AS OF CHANGE: 20260528 EFFECTIVENESS DATE: 20260528 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Intelligent Therapeutics, Inc. CENTRAL INDEX KEY: 0002136711 ORGANIZATION NAME: EIN: 413597478 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-585514 FILM NUMBER: 261036551 BUSINESS ADDRESS: STREET 1: 220 EAST 11TH AVENUE SUITE 6 CITY: EUGENE STATE: OR ZIP: 97401 BUSINESS PHONE: 5412325062 MAIL ADDRESS: STREET 1: 220 EAST 11TH AVENUE SUITE 6 CITY: EUGENE STATE: OR ZIP: 97401 D 1 primary_doc.xml X0708 D LIVE 0002136711 Intelligent Therapeutics, Inc. 220 EAST 11TH AVENUE SUITE 6 EUGENE OR OREGON 97401 5412325062 DELAWARE None None Corporation true 2025 Jason Gallic 220 East 11th Avenue Suite 6 Eugene OR OREGON 97401 Executive Officer Director President and Chief Executive Officer Nathan Bernstein 220 East 11th Avenue Suite 6 Eugene OR OREGON 97401 Executive Officer Director Chief Technology Officer Thomas Emmons 220 East 11th Avenue Suite 6 Eugene OR OREGON 97401 Executive Officer Director Chief Financial Officer, Secretary Michael Zvolensky 220 East 11th Avenue Suite 6 Eugene OR OREGON 97401 Executive Officer Director Chief Science Officer David Shear 220 East 11th Avenue Suite 6 Eugene OR OREGON 97401 Director Other Technology Decline to Disclose 06b false 2026-05-13 false true true true true Simple Agreement for Future Equity (SAFE) false 0 700000 100000 600000 false 2 0 0 0 false Intelligent Therapeutics, Inc. /s/ Jason Gallic Jason Gallic President 2026-05-28